# A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

> **NCT06640920** · PHASE1 · COMPLETED · sponsor: **Uniquity One (UNI)** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Cohort A
- **BIOLOGICAL:** Cohort B
- **BIOLOGICAL:** Cohort C
- **BIOLOGICAL:** Cohort D

## Key facts

- **NCT ID:** NCT06640920
- **Lead sponsor:** Uniquity One (UNI)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-29
- **Primary completion:** 2024-10-29
- **Final completion:** 2024-10-29
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06640920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06640920, "A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06640920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*